Mirati Therapeutics, Inc.

CIK 1576263 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mirati Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2024SC 13G/A0001172661-24-001279
Feb 14, 2024SC 13G0001104659-24-023741
Feb 14, 2024SC 13G/A0000902664-24-001600
Feb 14, 2024SC 13G/A0000902664-24-001549
Feb 13, 2024SC 13G/A0001104659-24-021476
Feb 9, 2024SC 13G/A0000895421-24-000141
Feb 9, 2024SC 13G0000895421-24-000138
Feb 8, 2024SC 13G/A0000902219-24-000102
Feb 2, 202415-12G0001140361-24-005311
Jan 31, 2024SC 13G0001086364-24-006031
Jan 25, 2024SC 13D/A0000895345-24-000018
Jan 25, 202440000895345-24-000019
Jan 24, 2024EFFECT9999999995-24-000186
Jan 24, 2024EFFECT9999999995-24-000187
Jan 24, 2024EFFECT9999999995-24-000189
Jan 23, 2024S-8 POS0001140361-24-003319
Jan 23, 202440001140361-24-003535
Jan 23, 202440001140361-24-003529
Jan 23, 202440001140361-24-003528
Jan 23, 2024S-8 POS0001140361-24-003323
Jan 23, 2024S-8 POS0001140361-24-003321
Jan 23, 2024POSASR0001140361-24-003299
Jan 23, 2024S-8 POS0001140361-24-003314
Jan 23, 2024POS AM0001140361-24-003291
Jan 23, 202440001140361-24-003533